Moffitt Cancer Center and Research Institute — Tampa, Florida

Public research footprint of Moffitt Cancer Center and Research Institute, compiled from the ClinicalTrials.gov public registry.

696

Registered studies

Active

Recruiting now

484

Completed

118

Stopped or withdrawn

Most-studied conditions

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET… · PDAC - Pancreatic Ductal Adenocarcinoma · Follicular Lymphoma · Advanced Solid Tumor

Recently updated registry entries

NCT06128551 — Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in… (Recruiting)
NCT07227350 — L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) (Recruiting)
NCT03108495 — Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Moffitt Cancer Center and Research Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.